Ghost Tree Capital, LLC Otonomy, Inc. Transaction History

Ghost Tree Capital, LLC

  • $245 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022
SELL
$1.69 - $2.31 $760,500 - $1.04 Million
-450,000 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$2.49 - $6.23 $622,500 - $1.56 Million
250,000 Added 125.0%
450,000 $1.15 Million
Q4 2020

Feb 16, 2021
BUY
$3.48 - $6.47 $696,000 - $1.29 Million
200,000 New
200,000 $1.29 Million

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email